X0202 SCHEDULE 13G/A 0001094891-25-000002 0001965743 XXXXXXXX LIVE 1 Common Stock, Par Value $0.001 Per Share 03/27/2026 0001624326 PAVmed Inc. 70387R502 360 MADISON AVENUE 360 MADISON AVENUE NEW YORK NY 10017 Rule 13d-1(c) Tasso Partners, LLC DE 912996.00 0.00 912996.00 0.00 912996.00 14.3 OO Dana Carrera X1 914246.00 0.00 914246.00 0.00 914246.00 14.3 IN PAVmed Inc. 360 MADISON AVENUE, 360 MADISON AVENUE, NEW YORK, NEW YORK, 10017. This amended Schedule 13G is filed by Tasso Partners, LLC ("Tasso Partners") and Dana Carrera ("Ms. Carrera," and together with Tasso Partners, the "Reporting Persons"). Ms. Carrera controls Tasso Capital, LLC, which in turn controls Tasso Partners. The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 99.1 to the initial Schedule 13G, pursuant to which such Reporting Persons have agreed to file the Schedule 13G and all amendments thereto jointly in accordance with the provisions of Rule 13d-1(k) of the Act. Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The filing of this Schedule 13G should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the shares of Common Stock reported herein. The principal business address of each of the Reporting Persons is: P.O. Box 503, Rumson, NJ 07760. Tasso Partners is a limited liability company formed under the laws of Delaware. Ms. Carrera is a citizen of the United States. Y Tasso Partners beneficially owns 912,996 shares of common stock. Ms. Carrera may be deemed to beneficially own the shares of common stock held by Tasso Partners, because Ms. Carrera indirectly controls Tasso Partners. Ms. Carrera beneficially owns an additional 1,250 shares of common stock. Tasso Partners and Ms. Carrera beneficially own 14.3% of the outstanding shares of common stock. The percentage of beneficial ownership is calculated based on 6,383,089 shares of common stock outstanding as of March 27, 2026, as set forth in the Company's annual report on Form 10-K filed on March 27, 2026. Tasso Partners: 912,996 Ms. Carrera: 914,246 Tasso Partners: 0 Ms. Carrera: 0 Tasso Partners: 912,996 Ms. Carrera: 914,246 Tasso Partners: 0 Ms. Carrera: 0 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Tasso Partners, LLC /s/ Dana Carrera 04/03/2026 Dana Carrera /s/ Dana Carrera 04/03/2026